大鼠脑内血管紧张素Ⅱ参与电针耐受的证据

本工作将AⅡ,抗体或受体拮抗剂Saralasin注入大鼠侧脑室以去除脑内AⅡ的作用,观察其对电针耐受动态过程的影响。结果表明,侧脑室注射AⅡIgG(20μg)或Saralasin(20μg)可明显推迟连续6轮电针造成的电针耐受(P<0.05,ANOVA)。给大鼠连续5轮电针造成耐受后,脑室注射AⅡIgG可部分翻转电针耐受,使电针镇痛作用恢复到耐受前水平的60％(P<0.01,ANOVA)。放免测定表明,未经电针的大鼠CSF中AⅡ-ir为16.4±3.4fmol/0.1ml;电针1h CSF中AⅡ-ir增高至44.8±6.6mol/0.1ml;电针2h达71.1±6.8fmol/0.1ml;以后逐渐波动下降,电针6h CSF中AⅡ-ir仍高于对照组1.3倍。说明电针耐受时释放剑CSF中的AⅡ增多。综合以上结果可以认为,脑内AⅡ任电针耐受的形成中起着重要作用。     

100 Hz电针耐受时大鼠脑和脊髓K受体结合特性的改变

本文采用放射配体结合实验研究了100 Hz电针耐受发生发展过程中大鼠脑和脊髓κ受体结合特性的变化.大鼠每天给予100Hz电针1次(30min),连续7 d.分别在电针的第1、3、5、7天取不同脑区进行观察.结果表明:在100Hz电针耐受期间,大鼠中脑、纹状体、脊髓、皮层和脑桥/延髓的κ受体均表现为下调,但在不同脑区κ受体下调的时程不同.在大鼠皮层和脑桥/延髓,电针第1天即引起κ受体下调,并在全过程(7 d)内保持下调状态.脊髓中的κ受体先上调后下调,而中脑和纹状体κ受体下调的时程与100Hz慢性电针耐受的发生发展相平行,提示该脑区的κ受体下调可能参与100Hz慢性电针耐受的形成.大部分脑区κ受体对[3H]-U69593亲和力的变化不明显,只有中脑在受体总数下降的同时亲和力有所升高(Kd值下降).上述结果表明,每天给予100Hz电针连续7 d,引起脑内特别是中脑和纹状体中κ受体数目显著下调,这种变化是否参与电针耐受的形成机制值得进一步研究.     

椎管内注射牛肾上腺髓质22肽差异性翻转吗啡耐受作用

牛肾上腺髓质22肽（bovine adrenal medulla22,BAM22）是脑啡肽原A的一种降解产物,与阿片受体和感觉神经元特异性受体（sensory neuron-specific receptor,SNSR）均有亲合力。本研究的目的是探讨BAM22对吗啡耐受的影响。连续7d对大鼠椎管内注射20μg吗啡形成吗啡耐受后,分为吗啡组、盐水组和BAM22组,第8天三组大鼠椎管内分别注射吗啡、生理盐水和BAM22,第9天三组大鼠椎管内均注射吗啡后,运用撤足反射、福尔马林实验和免疫组织化学等方法观察吗啡的作用效果。结果显示：在撤足反射实验中,BAM22组的吗啡能延长撤足反射潜伏期最大可能作用的48．5％,并持续约1h：在福尔马林实验中,BAM22组的吗啡能分别缩短福尔马林引起的第一期和第二期疼痛行为变化3．2min和24min,比盐水组分别减少45％和82％（P〈0．05,P〈0．001）;此外,在免疫组织化学实验中,BAM22组的吗啡能显著减少热刺激引起的脊髓背角c-Fos蛋白表达,其Ⅰ-Ⅱ层、Ⅲ-Ⅳ层和Ⅴ-Ⅵ层均减少约80％（P〈0．001）。本研究从整体和细胞水平表明,BAM22能翻转吗啡的耐受,这种作用在持续性疼痛模型中的表现要比急性痛中更为明显,显示BAM22对吗啡耐受的差异性调制;同时也提示感觉神经元特异性受体可能参与吗啡耐受的调制。     

低频和高频电针镇痛由脊髓水平不同类型的阿片受体介导:交叉耐受试验

以往的工作表明,给大鼠低频或高频电针在脊髓中分别释放出脑啡肽或强啡肽,产生镇痛效果。本工作用交叉耐受方法对此进行检验并进一步分析其受体机制。结果表明:(1) 给大鼠2Hz电针电针6h,镇痛作用逐渐降低导致耐受后,100Hz电针仍有明显的镇痛作用;100Hz耐受后,2Hz电针仍有效。说明低频和高频电针镇痛之间无明显的交叉耐受。(2) 100Hz电针耐受后,k激动剂强啡肽A(1—13)的脊髓镇痛作用明显减弱,而δ激动剂[(?)]enkephalin(DPDPE)仍保持明显的镇痛作用。(3) 2Hz电针耐受后,DPDPE的镇痛效果显著降低,而强啡肽A(1—13)的镇痛作用不受影响。根据以上的交叉耐受实验结果可以认为,脊髓中δ型阿片受体参与2Hz电针镇痛,而κ型阿片受体参与100Hz电针镇痛。     

吗啡耐受大鼠心房心钠素的释放及其基因转录

本工作应用心钠素放射免疫测定和分子杂交技术首次发现,吗啡耐受大鼠血浆心钠素水平显著降低,心房内心钠素含量明显升高,同时心房内心钠素特异性mRNA水平也相应提高,提示在吗啡耐受时大鼠心房内心钠素的合成和贮存增加,释放减少。     

家兔电针镇痛与吗啡镇痛的交叉耐受

本工作在同一实验曰给雄性家兔一侧后肢“足三里”-“昆仑”穴电针6轮可产生电针耐受,电针耐受家兔的吗啡镇痛效果也显著降低,对吗啡有交叉耐受。自家兔耳缘静脉连续两晶点滴盐酸吗啡(每日50毫克/公斤),可产生吗啡耐受;吗啡耐受兔的电针镇痛效果也显著减弱,产生电针交叉耐受。电针镇痛与吗啡镇痛之间存在着相互交叉耐受,说明两者的发生机理有相似之处。     

孕烷醇酮对应激性高血压大鼠血压的影响

实验探讨了孕烷醇酮(pregnanolone,PGN)对应激性高血压(stress-induced hypertension,SIH)大鼠血压影响的可能机制。采用电击足底结合噪声应激刺激的方法制备应激性高血压大鼠模型,观察每天应激刺激前腹腔注射PGN(0.24 mg/kg)对应激大鼠血压的影响,并观察PGN对应激刺激引起大鼠血中血管紧张素Ⅱ(angiotensin Ⅱ,Ang Ⅱ)含量和大鼠脑内Fos蛋白样免疫反应(FLI)神经元表达的影响。将动物随机分为正常对照组、应激1 h组、应激1 h PGN组、应激15 d组和应激15 d PGN组。实验结果如下:应激15 d PGN组大鼠尾动脉收缩压升高幅值较应激15 d组大鼠尾动脉收缩压升高幅值明显降低(P<0.001)。同时,应激1 h组及应激15 d组血中Ang Ⅱ含量与对照组相比有显著升高(均P<0.001);应激1 h PGN组及应激15 d PGN组大鼠血中Ang Ⅱ含量分别显著低于应激1 h组及应激15 d组(均P<0.05);应激15 d组血中Ang Ⅱ含量较应激1 h组高(P<0.05)。正常对照组、应激15 d组、应激15 d PGN组大鼠脑内仅见少数FLI神经元。与对照组相比,应激1 h组大鼠脑内外侧缰核(LHb)、内侧缰核(MHb)、室旁核(PVN)、杏仁中央核(CeA)和下丘脑外侧区(LH)等部位可见FLI神经元显著增加,而腹腔注射PGN后再应激1 h,可抑制上述效应。结果提示,PGN可抑制SIH大鼠血压升高的程     

100Hz电针刺受时大鼠脑和脊髓k受体结构特性的改变

西方采用放射配体结合实验研究了１００ＨＺ电针耐受发生发展过程中大鼠脑和脊髓Ｋ受体结构特性的变化。大鼠每天给予１００ＨＺ电针１次,连续７ｄ。分别在电针的第１、３、５、７天取不同脑区进行观察。     

慢性吗啡耐受大鼠脑内孤啡肽生成与释放增加

本文彩放射免疫分析法测定了慢性吗啡耐受过程中大鼠脑室灌流液、中脑导水管周围灰质（ＰＡＧ）及杏仁核中孤啡肽（ＯＦＱ）免疫活性的动态变化。结果观察到：（１）大鼠连续５ｄ皮下注射递增剂量的盐酸吗中民慢性吗啡耐受,其脑室灌流中ＯＦＱ－ｉｒ随吗啡注射剂量和注射次数的增加逐渐上升,第５ｄ注射后较对照组升高了５２％;（２）皮下注射吗啡１ｄ、３ｄ、５ｄ的大鼠ＰＡＧ中ＯＦＱ－ｉｒ比对照组分别升高了１７％、４８％和８     

Nω-硝基-L-精氨酸甲酯抑制吗啡镇痛耐受大鼠中脑和脊髓一氧化氮合酶/N-甲基-D-天冬氨酸受体表达上调

采用热甩尾测痛法观察全身应用非特异性一氧化氮合酶（nitric oxide synthase,NOS）抑制剂——N^ω-硝基-L-精氨酸甲酯（L-NAME）对吗啡镇痛耐受形成的影响,并通过观察脊髓和中脑神经元型NOS（nNOS）和N-甲基-D-天冬氨酸（NMDA）受体亚单位表达的变化来阐释NO／NMDA受体在吗啡镇痛耐受形成中的作用。将36只健康成年Sprague-Dawley大鼠平均分为6组（每组6只）：1组为对照组,皮下注射生理盐水1ml;2、3、4、5和6组为处理组,分别皮下注射L-NAME10mg／kg、L-NAME20mg／kg、吗啡10mg／kg、L-NAME10mg／kg＋吗啡10mg／kg、L-NAME20mg／kg＋吗啡10mg／kg,每天2次。在注射前测量大鼠的热甩尾潜伏期（tail-flick latency,TFL）基础值,随后每天第一次给药50min后测量其TFL。第8天最后一次给药80min后（除2组和5组之外）断头取脊髓和中脑,采用RT-PCR技术测量nNOS以及NMDA受体1A（NR1A）和2A（NR2A）亚单位的表达。结果显示,2组大鼠第1天至第7天的TFL与基础值相比无显著差异;3组第7天时的TFL仍显著高于基础值;4组的TFL在第1天时最高,第2至第6天期间逐渐降低,第6天时与基础值相比无显著差异：5组的TFL在实验过程中呈下降趋势,虽然第7天时较第1天有所降低,但是仍然显著高于基础值;6组的TFL变化趋势与5组相同。PT—PCR分析结果显示,与1组相比,3组脊髓和中脑的nNOS mRNA表达显著降低,但NR1A mRNA和NR2A mRNA表达无显著改变;4组的nNOS mRNA、NR1A mRNA和NR2A mRNA表达均显著高于1组。与4组相比,6组的nNOS mRNA、NR1A mRNA和NR2A mRNA表达均显著降低。结果提示,吗啡镇痛耐受大鼠脊髓和中脑的nNOS和NMDA受体表达增加,联合应用L—NAME可抑制长期应用吗啡所致的nNOS表达增加和NMDA受体上调,延缓吗啡镇痛耐受的形成。本研究结果提示,脊髓和中脑的NO／NMDA受体与吗啡镇痛耐受形成密切相关。     

低、高频电针诱导原癌基因c－fos／c－jun和阿片肽基因表达及其关系的比较研究

本工作对低频（２Ｈｚ）和高频（１００Ｈｚ）电针引起大鼠中枢Ｆｏｓ／Ｊｕｎ表达和三类阿片肽基因表达进行了详细的比较研究,并用针对ｃ－ｆｏｓ／ｃ－ｊｕｎ的反义寡核苷酸（ＯＤＮｓ）对电针引起的Ｆｏｓ／Ｊｕｎ表达进行选择性阻断,然后观察阿片肽基因表达是否受到影响,以确定Ｆｏｓ／Ｊｕｎ复合物在电针引起阿片肽基因表达中的作用。主要结果如下：（１）２Ｈｚ和１００Ｈｚ电针引起脑内不同部位的Ｆｏｓ／Ｊｕｎ表达;（２）２Ｈｚ电针使前脑啡肽原（ＰＰＥ）ｍＲＮＡ表达大幅度增高,１００Ｈｚ电针也能增加ＰＰＥｍＲＮＡ的转录,但不如２Ｈｚ电针的作用显著;但１００Ｈｚ电针能使某些脑区的前强啡肽原（ＰＰＤ）基因转录加速,而２Ｈｚ电针没有这一作用;（３）用ｃ－ｆｏｓ／ｃ－ｊｕｎ反义ＯＤＮｓ特异地阻断Ｆｏｓ／Ｊｕｎ表达后,电针引起的ＰＰＤ转录加速被明显阻断,而ＰＰＥ表达不受影响。提示Ｆｏｓ／Ｊｕｎ是电针引起ＰＰＤ（而非ＰＰＥ）基因表达的转录因子。     

Increased brain P-glycoprotein in morphine tolerant rats

The objective of this study was to determine whether chronic morphine exposure increased P-glycoprotein in rat brain. Male Sprague-Dawley rats were treated with morphine, saline, or dexamethasone for 5 days. On day 6, antinociceptive effect was measured to evaluate the extent of functional tolerance to morphine. Brain P-glycoprotein was detected by Western blot analysis of whole brain homogenate. Morphine- and dexamethasone-treated rats exhibited decreased antinociceptive response when compared to saline-treated controls. Brain P-glycoprotein was approximately 2-fold higher in morphine-treated rats compared to saline controls based on Western blot analysis. Chronic morphine exposure appears to increase P-glycoprotein in rat brain. P-glycoprotein induction may enhance morphine efflux from the brain, thus reducing morphine's pharmacologic activity. Induction of P-glycoprotein may be one mechanism involved in the development of morphine tolerance.     

2Hz和100Hz电针加速脑内三种阿片肽基因表达

我室以往的工作证明２Ｈｚ和１００Ｈｚ电针可引起中枢释放不同种类的阿片肽,本工作试图阐明不同频率的电针是否影响三种阿片肽的基因转录。用地高辛标记的反义ｃＲＮＡ探针进行原位杂交,显示大鼠脑内前脑啡肽原（ＰＰＥ）,前强啡肽强（ＰＰＤ）和前阿黑皮素原（ＰＯＭＣ）ｍＲＮＡ。结果：（１）低、高频电针均不影响ＰＯＭＣ ｍＲＮＡ的水平。（２）对ＰＰＥ的影响,两种频率电针诱导脑干网状结构头端腹内侧区ＰＰＥ ｍＲＮＡ     

High and low frequency electroacupuncture analgesia are mediated by different types of opioid receptors at spinal level: a cross tolerance study

Previous studies have shown that rats subjected to low or high frequency electroacupuncture (EA) stimulation release enkephalins or dynorphins respectively to produce analgesia. This conclusion was tested in the present study by using cross tolerance technique for further analysing their receptor mechanisms. The main results were as follows: (1) In rats subjected to 2 Hz EA for 6 h, there was a gradual decrease in the analgesic effect, leading to a state of tolerance to 2 Hz EA analgesia. These rats, however, still responded to 100 Hz EA. Likewise, rats made tolerant to 100 Hz EA were still effective to 2 Hz EA stimulation, showing not significant cross tolerance between 2 Hz and 100 Hz EA analgesia. (2) Rats made-tolerant to 100 Hz EA analgesia showed a diminished response to intrathecal dynorphin A (1-13), a kappa agonist, whereas the analgesic effect of the delta agonist [D-Pen2, D-pen5] enkephalin (DPDPE) remained intact. (3) Rats made tolerant to 2 Hz EA analgesia showed a cross tolerance to DPDPE, but not to dynorphin A (1-13). Results obtained from aforementioned cross tolerance studies suggest that 2 Hz and 100 Hz EA analgesia are mediated by delta and kappa opioid receptors, respectively, at the spinal cord of the rat.     

Changes in [3H]Nitrendipine Binding and γ-Aminobutyric Acid Release in Rat Hippocampus Following Repeated Morphine Administration

An antagonistic effect of calcium on the action of morphine was studied in rat hippocampal slices. The effect of repeated administration of morphine on gamma-aminobutyric acid (GABA) release and binding of [3H]nitrendipine, a calcium antagonist, was also examined. (1) In rat brain hippocampal slices, morphine enlarged the amplitude of the field potentials evoked in pyramidal neurons, disinhibiting them through basket cells. When the calcium concentration was elevated, potentiation of the field potentials by morphine was reduced. Decrease of the calcium concentration, on the other hand, enhanced the potentiating effect of morphine. Following repeated administration of morphine, its enhancing effect on the field potentials in slices was not observed. (2) In hippocampal membrane fractions obtained from rats repeatedly treated with morphine, enhancement of [3H]nitrendipine binding was observed. (3) In hippocampal slice preparations from rats receiving morphine repeatedly, K+ (45 mM)-stimulated [3H]GABA efflux was enhanced. The above results indicate that morphine antagonizes calcium, thereby reducing the release of transmitters. Furthermore, increase in calcium channels following repeated treatment of rats with morphine may explain the mechanism underlying development of tolerance.     

电针对吗啡戒断大鼠体质量和胃电图的影响

通过给大鼠连续注射递增量吗啡8d,建立吗啡戒断大鼠模型,停药后第2d开始给于强度为2mA,频率2～100Hz混频刺激.各组大鼠分别在实验前、实验第8d和实验第11d 18∶ 00测量体质量,在胃体、胃窦、体表投影处分别记录胃电图.观察电针足三里穴对其体质量和胃电图的影响.实验表明,模型组大鼠体质量与正常组比明显降低(P《0.01),胃电图频率、幅值改变,节律紊乱.电针组大鼠体质量与正常组比无显著差异,胃电图均有不同程度恢复.电针对吗啡戒断大鼠的体质量和胃肠功能紊乱具有良性调整作用.     

Rapid, transient, and dose-dependent expression of hsp70 messenger RNA in the rat brain after morphine treatment

Induction of Hsp70 in the brain has been reported after intake of drugs of abuse like amphetamine and lysergic acid diethylamide. In this investigation, gene expression of Hsp70 and other heat shock genes in the rat brain was studied in response to morphine. Twenty milligrams per kilogram morphine intraperitoneally resulted in a marked induction of Hsp70 messenger RNA (mRNA) expression in the frontal cortex with a maximum increase of 13.2-fold after 2 hours. A moderate increase of Hsp27 mRNA expression (6.7-fold) could be observed after 4 hours, whereas mRNA expression of Hsp90 and of the constitutive Hsc70 did not exceed a mean factor of 1.8-fold during the 24 hours interval. The increase in Hsp70 mRNA was dose dependent, showing a significant elevation after doses ranging from 10 to 50 mg/kg morphine. In situ hybridization revealed enhanced Hsp70 mRNA expression mainly in cortical areas, in the hippocampus, in the paraventricular and supraoptic nuclei of the hypothalamus, in the locus coeruleus, as well in the pineal body. The double in situ hybridization technique revealed increased Hsp70 mRNA expression mainly in VGLUT1-positive neurons and to a lesser extent in olig1-positive oligodendroglia. Immunohistochemistry revealed a marked increase of Hsp70 protein in neuronal cells and blood vessels after 12 hours. In contrast to animal experiments, morphine did not increase Hsp70 mRNA expression in vitro in micro-opioid receptor (MOR1)-expressing human embryonic kidney 293 cells, suggesting no direct MOR1-mediated cellular effect. To exclude a body temperature-related morphine effect on Hsp70 mRNA expression, the temperature was recorded. Five to 20 mg/kg resulted in hyperthermia (maximum 40.6 degrees), whereas a high dose (50 mg/kg) that produced the highest mRNA induction, showed a clear hypothermia (minimum 37.2 degrees C). These findings argue against the possibility that Hsp70 induction by morphine is caused by its effect on body temperature. It may be speculated that increased expression of Hsp70 after morphine application protects brain structures against potentially hazardous effects of opiates.     

Induction of glycerol phosphate dehydrogenase gene expression during seizure and analgesia

Using mRNA differential display, we found that the gene for NAD(+)-dependent glycerol phosphate dehydrogenase (GPDH; EC 1.1.1.8) is induced in rat brain following seizure activity. Northern blot and in situ hybridization analysis confirmed the differential display results; they also showed, in a separate model of neuronal activation, that after thermal noxious stimulation of the hind-paws, a similar increase in GPDH mRNA occurs in the areas of somatotopic projection in the lumbar spinal cord. Surprisingly, administration of analgesic doses of morphine or the nonsteroidal antiinflammatory drugs aspirin, metamizol (dipyrone), and indomethacin also increased GPDH mRNA levels in rat spinal cord. The opioid receptor antagonist naloxone completely blocked morphine induction of GPDH but had no effect on GPDH induction by noxious heat stimulation or metamizol treatment, implicating different mechanisms of GPDH induction. Nevertheless, in all cases, induction of the GPDH gene requires adrenal steroids and new protein synthesis, as the induction was blocked in adrenalectomized rats and by cycloheximide treatment, respectively. Our results suggest that the induction of the GPDH gene upon peripheral noxious stimulation is related to the endogenous response to pain as it is mimicked by exogenously applied analgesic drugs.